Trademarkia Logo

Canada

C$
MISCELLANEOUS DESIGN
APPROVED

on 4 Dec 2024

Last Applicant/ Owned by

Pfizer Inc.

66 Hudson Boulevard EastNew York, New York 10001-2192

US

Serial Number

2103883 filed on 30th Apr 2021

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

MISCELLANEOUS DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations, namely, human growth hormones

Vienna Information


24 . 17 . 20

Check signsCoches, signes de validation

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

24 . 13 . 9

Crosses formed by intersecting linesCroix formées de lignes qui se coupent

24 . 13 . 25

Other crossesAutres croix

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations, namely, human growth hormones


Classification kind code

11

Mark Details


Serial Number

2103883

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 4th Dec 2024
Advertised
Submitted for opposition 26
on 8th Nov 2024
Approved
Submitted for opposition 27
on 8th Nov 2024
Approval Notice Sent
Submitted for opposition 22
on 31st Oct 2024
Search Recorded
Submitted for opposition 135
on 30th Jun 2023
Amendment to Application
Submitted for opposition 287
on 4th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 30th Apr 2021
Filed
Submitted for opposition 1
on 30th Apr 2021
Created
Submitted for opposition 31
on 30th Apr 2021
Formalized